NEW YORK (GenomeWeb News) – Agilent Technologies today said that it will collaborate with sera prognostics on the development of proteomic assays for early prediction of pregnancy complications.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.